FOXA
60
-3
CMG
69
-4
CFG
46
2
BWA
49
-6
XRX
52
3
CSX
44
-2
ADM
30
-3
MUR
34
-10
MCHP
43
6
EL
34
-3
VMC
48
-2
CHRW
51
-6
PSA
48
-2
TSN
28
-2
MAS
52
-2
AN
50
-5
UHS
52
2
MTCH
48
11
EQIX
60
-3
SCHW
53
-11
FOXA
60
-3
CMG
69
-4
CFG
46
2
BWA
49
-6
XRX
52
3
CSX
44
-2
ADM
30
-3
MUR
34
-10
MCHP
43
6
EL
34
-3
VMC
48
-2
CHRW
51
-6
PSA
48
-2
TSN
28
-2
MAS
52
-2
AN
50
-5
UHS
52
2
MTCH
48
11
EQIX
60
-3
SCHW
53
-11
Financhill
Back

NeuroPace Stock Predictions

The dark truth about AI

Click here to learn more...
Sell
44

NPCE
NeuroPace

Last Price:
10.93
Seasonality Move:
54.77%

7 Day Trial

ALL ACCESS PASS

$ 7

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)

NeuroPace Stock Forecast

  • Over the next 52 weeks, NeuroPace has on average historically risen by 109.3% based on the past 3 years of stock performance.
  • NeuroPace has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is NeuroPace Stock Undervalued?
    The current NeuroPace [NPCE] share price is $11.03. The Score for NPCE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • NPCE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will NeuroPace Stock Go Up Next Year?

  • Over the next 52 weeks, NeuroPace has on average historically risen by 109.3% based on the past 3 years of stock performance.

NeuroPace Stock Rating

Sell
44
NeuroPace (NPCE) is a Sell

Is NeuroPace overpriced?

  • NeuroPace has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

NeuroPace Stock Price History

Is NPCE stock going to rise?

  • The current trend is moderately bullish and NPCE is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
neuropace.com

52-Week Data

52-Week High:
18.15
52-Week Low:
5.45

Prediction Charts

Market Cap:
329.22M
Price in USD:
11.03
Volume:
56.28K
Beta:
2.07

Technical Analysis

SMA50:
8.26
SMA100:
7.76
SMA200:
9.11
52-Wk Change:
34.35%

Stock Predictions

  • Is NeuroPace stock public?
    Yes, NeuroPace is a publicly traded company.
  • What is the NeuroPace stock quote today?
    The NeuroPace stock price is 11.03 USD today.
  • How to buy NeuroPace stock online?
    You can buy NeuroPace shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-25 9.40 10.66 10.77 9.40
Nov-26 10.67 10.20 10.67 10.10
Nov-27 10.20 10.25 10.46 9.79
Nov-29 10.43 10.60 10.72 10.42
Dec-2 10.87 11.29 11.73 10.61
Dec-3 11.25 11.93 12.43 11.09
Dec-4 11.89 11.19 11.89 10.70
Dec-5 11.09 11.28 11.83 10.89
Dec-6 11.46 11.28 11.55 11.20
Dec-9 11.29 10.95 11.45 10.94
Dec-10 10.71 11.51 11.68 10.47
Dec-11 11.56 11.08 12.00 10.90
Dec-12 10.95 10.91 11.21 10.35
Dec-13 10.98 11.03 11.09 10.00

NeuroPace Earnings

NeuroPace Earnings Report: Per Share NeuroPace Earnings Q1 Q2 Q3 and Q4 last year and next year.

NeuroPace Forecast Revenue Growth

NeuroPace Stock Analysis: Historical quarterly revenues per share for NeuroPace and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and an increase next year of $0.10 per share.

* NeuroPace stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.